News
A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...
European regulators have finally approved the Alzheimer’s treatment Leqembi after an advisory committee initially rejected ...
Lifeforce, the world's leading longevity medicine program, has introduced the Lifeforce Brain Protection Program, a first-of-its-kind solution for people wanting to proactively take control of their ...
Around 70% of college students report getting less than eight hours of sleep a night. With looming deadlines, buzzing social ...
Leqembi gains European approval after CHMP reversal, despite safety concerns tied to brain swelling and bleeding in Alzheimer ...
19h
Pharmaceutical Technology on MSNEC authorises Eisai and Biogen’s lecanemab for Alzheimer’sEisai and Biogen have received marketing authorisation from the European Commission (EC) for Leqembi (lecanemab) to treat ...
A nutrition expert reveals which foods to eat and which to avoid to help lower the risk of stroke. You might not remember ...
7h
News-Medical.Net on MSNNew scoring system predicts stroke risk and reduces need for surgeryResearchers at UCL have tested a new scoring system to measure the risk of stroke in patients with narrowed arteries due to ...
Eisai and Biogen can finally put their European regulatory uncertainty surrounding Alzheimer's disease medicine Leqembi ...
A micrograph showing inflammatory responses in the cortex of the new model mouse. Alzheimer's disease patients and mouse ...
Justin Hagenman was a 23rd round pick in 2018. The Dodgers scout who signed him, Jonah Rosenthal, is recovering from a stroke in December.
A study of about 250 patients in America, published in 2024 in the New England Journal of Medicine, linked the presence of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results